Published in Nat Commun on January 01, 2013
Measurement of the first ionization potential of lawrencium, element 103. Nature (2015) 1.18
Unexpected Behavior of the Heaviest Halogen Astatine in the Nucleophilic Substitution of Aryliodonium Salts. Chemistry (2016) 0.79
Towards high-resolution laser ionization spectroscopy of the heaviest elements in supersonic gas jet expansion. Nat Commun (2017) 0.75
Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6. J Nucl Med (2007) 1.57
Synthesis of a new element with atomic number Z = 117. Phys Rev Lett (2010) 1.36
Applications of 211At and 223Ra in targeted alpha-particle radiotherapy. Curr Radiopharm (2011) 1.04
Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model. Nucl Med Biol (2011) 0.97
Astatine-211--tellurium radiocolloid cures experimental malignant ascites. Science (1981) 0.95
Upgrade of the resonance ionization laser ion source at ISOLDE on-line isotope separation facility: new lasers and new ion beams. Rev Sci Instrum (2012) 0.91
Astatine standard redox potentials and speciation in acidic medium. J Phys Chem A (2010) 0.90
Early onset of ground state deformation in neutron deficient polonium isotopes. Phys Rev Lett (2011) 0.86
New type of asymmetric fission in proton-rich nuclei. Phys Rev Lett (2010) 0.81
Assessment of an effective quasirelativistic methodology designed to study astatine chemistry in aqueous solution. Phys Chem Chem Phys (2011) 0.81
Two-component relativistic density-functional calculations of the dimers of the halogens from bromine through element 117 using effective core potential and all-electron methods. J Chem Phys (2006) 0.81
Ionization potentials, electron affinities, resonance excitation energies, oscillator strengths, and ionic radii of element Uus (Z = 117) and astatine. J Phys Chem A (2010) 0.80
Risk factors for sporadic Campylobacter infections: results of a case-control study in southeastern Norway. J Clin Microbiol (1992) 3.18
Yersinia enterocolitica in drinking-water. Scand J Infect Dis (1972) 2.79
[Supplement to the antigenic schema of Yersinia enterocolitica]. Ann Inst Pasteur (Paris) (1972) 2.52
Physical performance of the new hybrid PET∕CT Discovery-690. Med Phys (2011) 2.08
Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (2001) 2.00
Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA). Br J Cancer (2007) 2.00
Rapid identification of gram-negative rods using a three-tube method combined with a dichotomic key. Acta Pathol Microbiol Scand Suppl (1975) 1.98
Temperature-sensitive mutations in the III-IV cytoplasmic loop region of the skeletal muscle sodium channel gene in paramyotonia congenita. Cell (1992) 1.80
Modern sedentary activities promote overconsumption of food in our current obesogenic environment. Obes Rev (2011) 1.75
An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting. Ann Oncol (2012) 1.63
Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol (2001) 1.62
Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer (2012) 1.58
A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor cell line HPC-Y5. J Biol Chem (1994) 1.51
Isolation of a new human fetal liver cytochrome P450 cDNA clone: evidence for expression of a limited number of forms of cytochrome P450 in human fetal livers. Arch Biochem Biophys (1989) 1.49
Repeat hepatectomy for recurrent colorectal metastases. World J Surg (1998) 1.49
Nuclear isomers in superheavy elements as stepping stones towards the island of stability. Nature (2006) 1.48
Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am J Respir Crit Care Med (1999) 1.44
Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis. Ann Surg (1996) 1.43
FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer. Ann Oncol (2010) 1.42
[Motor neuropathy, putamen necrosis and optic nerve atrophy after acute methanol poisoning]. Rev Neurol (Paris) (1998) 1.41
Precise determination of the unperturbed 8B neutrino spectrum. Phys Rev Lett (2012) 1.39
Early re-feeding in the management of acute diarrhoea in infants of 0-1 year of age. Acta Paediatr (1995) 1.39
Effect of diclofenac pretreatment on pain during propofol injection. Anaesth Intensive Care (2004) 1.39
The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci Lett (1997) 1.39
Relationship of virulence-associated autoagglutination to hemagglutinin production in Yersinia enterocolitica and Yersinia enterocolitica-like bacteria. Infect Immun (1983) 1.35
FGFR2 gene amplification and clinicopathological features in gastric cancer. Br J Cancer (2012) 1.34
Emerging ethnic differences in lung cancer therapy. Br J Cancer (2008) 1.34
Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer. Br J Cancer (2011) 1.32
Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines. Oncogene (2007) 1.32
Gonadotrophin-releasing hormone pulse generator activity in the hypothalamus of the goat. J Neuroendocrinol (2009) 1.31
Epidemiology of Salmonella typhimurium O:4-12 infection in Norway: evidence of transmission from an avian wildlife reservoir. Am J Epidemiol (1998) 1.31
Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res (1991) 1.30
The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene. J Bone Joint Surg Br (2001) 1.27
Anti-obesity and anti-diabetic effects of CL 316,243, a highly specific beta 3-adrenoceptor agonist, in yellow KK mice. Life Sci (1994) 1.27
Epidemiological aspects of enteritis due to Campylobacter spp. in Norway. J Clin Microbiol (1984) 1.27
Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis. Neuromuscul Disord (1997) 1.24
Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. Biochem Biophys Res Commun (1993) 1.19
Successful transplant of a kidney with focal segmental glomerulosclerosis. Nephrol Dial Transplant (2001) 1.18
Abnormal discharge originates at the site of nerve injury in experimental constriction neuropathy (CCI) in the rat. Pain (1996) 1.18
Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells. Oncol Rep (1999) 1.17
Diagnosis and treatment of strictures and kinks in salivary gland ducts. J Oral Maxillofac Surg (2001) 1.16
Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest (1995) 1.16
Differential osteopontin expression in lung cancer. Cancer Lett (2001) 1.14
Unilateral hepatic artery reconstruction is unnecessary in biliary tract carcinomas involving lobar hepatic artery: implications of interlobar hepatic artery and its preservation. Hepatogastroenterology (2001) 1.14
Societal aspects of genetically modified foods. Food Chem Toxicol (2004) 1.13
ZNF143 interacts with p73 and is involved in cisplatin resistance through the transcriptional regulation of DNA repair genes. Oncogene (2007) 1.13
A profile of European ICU nursing. Intensive Care Med (1998) 1.13
Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification. Oncogene (2011) 1.13
Identification and characterization of three novel beta 1,3-N-acetylglucosaminyltransferases structurally related to the beta 1,3-galactosyltransferase family. J Biol Chem (2000) 1.13
Outbreak of Salmonella typhimurium infection traced to contaminated chocolate and caused by a strain lacking the 60-megadalton virulence plasmid. J Clin Microbiol (1990) 1.13
Serotype-related HEp-2 cell interaction of Yersinia enterocolitica. Infect Immun (1986) 1.13
Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line. Biochem Biophys Res Commun (1992) 1.12
Pattern of recurrence after resection for intraductal papillary mucinous tumors of the pancreas. World J Surg (1998) 1.12
Thiamine transport mutants of Saccharomyces cerevisiae. Biochim Biophys Acta (1975) 1.12
Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis. Clin Nephrol (2009) 1.11
Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene (2006) 1.11
A nuclear factor (NF2d9) that binds to the male-specific P450 (Cyp 2d-9) gene in mouse liver. Mol Cell Biol (1995) 1.11
EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib. Br J Cancer (2006) 1.10
Sources of sporadic Yersinia enterocolitica infections in Norway: a prospective case-control study. Epidemiol Infect (1994) 1.10
Mutations in SACS cause atypical and late-onset forms of ARSACS. Neurology (2010) 1.10
Bacterial adhesiveness and invasiveness in cell culture monolayer. Acta Pathol Microbiol Immunol Scand B (1982) 1.09
Identification of expressed genes characterizing long-term survival in malignant glioma patients. Oncogene (2006) 1.09
Guidelines and recommendations for assessment of somatosensory function in oro-facial pain conditions--a taskforce report. J Oral Rehabil (2011) 1.08
Comparison of epidemiological marker methods for identification of Salmonella typhimurium isolates from an outbreak caused by contaminated chocolate. J Clin Microbiol (1989) 1.08
Studies of pear-shaped nuclei using accelerated radioactive beams. Nature (2013) 1.08
Extrahepatic portal hypertension: a review of 70 cases. J Pediatr Surg (1978) 1.07
Treatment of angiolymphoid hyperplasia with eosinophilia with the carbon dioxide laser. J Dermatolog Treat (2004) 1.07
Candida norvegensis: a fluconazole-resistant species. Antimicrob Agents Chemother (1997) 1.06
Phylogenetic relationships of the genera Arthroderma and Nannizzia inferred from mitochondrial DNA analysis. Mycopathologia (1992) 1.05
Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy. Pharmacogenomics J (2010) 1.04
Characterization of two types of histone H2B genes from macronuclei of Tetrahymena thermophila. Nucleic Acids Res (1987) 1.04
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Eur J Neurol (2006) 1.04
Mixed bacteremia with Vibrio metschnikovii in an 83-year-old female patient. Scand J Infect Dis (1994) 1.04
Cyclic fatigue resistance of two reciprocating nickel-titanium instruments after immersion in sodium hypochlorite. Int Endod J (2012) 1.04
Decontamination efficacy of photon-initiated photoacoustic streaming (PIPS) of irrigants using low-energy laser settings: an ex vivo study. Int Endod J (2012) 1.03
Yersinia enterocolitica type 2 associated with disease in goat. Acta Vet Scand (1972) 1.03
Occurrence of mRNA for storage protein in dry soybean seeds. J Biochem (1978) 1.03
Hippocampal damage in the human brain after cardiac arrest. Cerebrovasc Dis (2000) 1.02
Clinical features of sporadic Campylobacter infections in Norway. Scand J Infect Dis (1992) 1.02
Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors. Bone Marrow Transplant (2011) 1.02
Combined effect of ALK and MEK inhibitors in EML4-ALK-positive non-small-cell lung cancer cells. Br J Cancer (2012) 1.02
Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells. Cancer Res (1996) 1.01
Clinical features of sporadic Yersinia enterocolitica infections in Norway. J Infect Dis (1992) 1.01
Rotation of a complex of the gamma subunit and c ring of Escherichia coli ATP synthase. The rotor and stator are interchangeable. J Biol Chem (2001) 1.01
Exposure to bacterial aerosols and work-related symptoms in sewage workers. Am J Ind Med (1994) 1.01
Efficacy of Echinacea purpurea in patients with a common cold. A placebo-controlled, randomised, double-blind clinical trial. Arzneimittelforschung (2001) 1.00
Plasmid characterization of Salmonella typhimurium transmitted from animals to humans. J Clin Microbiol (1985) 1.00
A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type I (PAI-1) in breast tumor cytosols. Int J Biol Markers (1997) 1.00
Erysipelas-like disease caused by Yersinia enterocolitica. Scand J Infect Dis (1974) 0.99
Fetus-specific expression of a form of cytochrome P-450 in human livers. Biochemistry (1990) 0.99
Clinical outcome for EML4-ALK-positive patients with advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy. Ann Oncol (2012) 0.99
Involvement of a chloroplast homologue of the signal recognition particle receptor protein, FtsY, in protein targeting to thylakoids. FEBS Lett (1999) 0.99